CClinicalTrials.gg
RecruitingNCT06089915RVZUUpdated Jun 15, 2026

Effectiveness of Robot-assisted Upper-limb Exercise in Cervical SCI

An interventional study of Standard occupational therapy and Robot-assisted exercise using Amadeo device and Armeo Spring exoskeleton in Cervical Vertebrae Injury, sponsored by University Rehabilitation Institute, Republic of Slovenia. Recruiting at 1 site in Slovenia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by University Rehabilitation Institute, Republic of Slovenia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the project is to test the effectiveness of robot-assisted upper-limb exercise in persons after cervical spinal cord injury. In a randomised controlled two-arm trial, the effect of adding two types of robot-assisted upper-limb exercise to standard occupational therapy will be tested. Three primary and two secondary outcomes will be assessed using well-established measures.

Read the detailed description

Unlike for persons after stroke, there is no high-quality evidence of the effectiveness of robot-assisted upper-limb exercise in persons after cervical spinal cord injury. For this reason, we are aiming to conduct a randomised trial. The trial will involve two groups of adult patients admitted to inpatient rehabilitation. One group will receive standard occupational therapy, tailored to the patient's needs and abilities, five times per week for 90 minutes. In addition to the standard occupational therapy, the other group will receive ten 30-minute session of robot-assisted exercise: five sessions of exercise for fingers and hand using a specialised device, and five sessions of gross-motor exercise using an exoskeleton. Three outcome measures will be used to comprehensively assess the patients at the beginning and at the end of the intervention, i.e., upon admission and discharge: the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP; general and Myelopathy version), the Spinal Cord Independence Measure (SCIM), and the Canadian Occupational Performance Measure (COPM). The progress in those measures will be compared between the two groups.

02

Conditions studied

  • Cervical Vertebrae Injury

Keywords

  • spinal cord injury
  • upper limbs
  • impairment
  • rehabilitation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ability to move unloaded upper limbs
  • at least 18 years of age
  • ability to sit for one hour
  • ability to understand the instructions for robot-assisted exercise

Exclusion criteria

Exclusion Criteria:

  • inability to sit for one hour
  • presence of hospital-acquired infection that requires isolation
  • bodily impairment other than spinal cord injury
  • inability to understand the instructions for robot-assisted exercise
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Occupational therapy + robot-assisted exercise

    Standard occupational therapy five times per week for 90 minutes (tailored to the patient's needs and abilities) + five 30' sessions (2-3 per week) of robot-assisted exercise for fingers and hand using Amadeo device + five 30' sessions (2-3 per week) of robot-assisted exercise using Armeo Spring exoskeleton for facilitating gross movements of upper limbs

    Behavioral: Standard occupational therapy · Device: Robot-assisted exercise using Amadeo device and Armeo Spring exoskeleton

  • Active comparator
    Occupational therapy only

    Standard occupational therapy five times per week for 90 minutes (tailored to the patient's needs and abilities)

    Behavioral: Standard occupational therapy

Interventions

  • BehavioralStandard occupational therapy

    Standard occupational therapy as part of inpatient rehabilitation

  • DeviceRobot-assisted exercise using Amadeo device and Armeo Spring exoskeleton

    Exercise for fingers and hand using Amadeo device plus gross-motor exercise using Armeo Spring exoskeleton

05

What researchers measure

Primary outcomes

  1. Difference in Graded Redefined Assessment of Strength, Sensibility and Prehension Version 2 (GRASSP V2) score

    Clinical impairment measure specific to the upper limb for use after tetraplegia that measures sensorimotor and prehension function through three domains; total score for each body side ranges from 0 to 94; higher scores mean a better outcome

    Time frame: Before intervention (at admission) and after the intervention (on average after 3 weeks)

  2. Difference in Graded Redefined Assessment of Strength, Sensibility and Prehension - Mielopathy (GRASSP-M) score

    Objective tool designed to characterize patients' functional impairment related to the upper limb, useful for diagnosing and quantifying mild dysfunction and monitoring patients for deterioration; total score for each body side ranges from 0 to 74; higher scores mean a better outcome

    Time frame: Before intervention (at admission) and after the intervention (on average after 3 weeks)

Secondary outcomes

  1. Difference in Spinal Cord Independence Measure (SCIM) score

    Assessement of performance in activities of daily living and mobility for individuals with spinal cord injury; score ranges from 0 to 100; higher scores mean a better outcome

    Time frame: Before intervention (at admission) and after the intervention (on average after 3 weeks)

  2. Difference in Canadian Occupational Performance Measure (COPM) results

    Individualized, client-centred outcome measure designed to capture a client's self-perception of performance in everyday living, over time; performance and satisfaction scores range from 1 to 10; higher scores mean a better outcome

    Time frame: Before intervention (at admission) and after the intervention (on average after 3 weeks)

06

Study locations

1 of 1 sites recruiting
  • University Rehabilitation Institute, Republic of Slovenia
    Ljubljana, 1000, Slovenia
    • Urška Kidrič Sivec, MD, MSc · Contact · urska.kidric@ir-rs.si · +386 1 4758438
    • Tibor Kafel, OT · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06089915
Lead sponsor
University Rehabilitation Institute, Republic of Slovenia
Responsible party
Sponsor
First posted
Oct 19, 2023
Start date
Sep 1, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 15, 2026

Study contacts

Metka Moharić, MD, PhD
Contact
metka.moharic@ir-rs.si
+386 1 4758441
Tibor Kafel, OT
principal investigator · University Rehabilitation Institute, Republic of Slovenia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion